Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dr Naader Noory`s formulas about diabetes mellitus.

Published byNaader Noory نادر نوری Modified over 4 years ago

Similar presentations

Presentation on theme: "Dr Naader Noory`s formulas about diabetes mellitus."— Presentation transcript:

1 Dr Naader Noory`s formulas about diabetes mellitus

2 Control of LDL in diabetics

3 New definition for Diabetes mellitus

4 HbA1c target number

5 Risk of developing diabetes in a child with family history of DM

Download ppt "Dr Naader Noory`s formulas about diabetes mellitus."

Similar presentations

Management of Diabetes Treat to Target Approach (A1c

Management of Diabetes Treat to Target Approach (A1c
Are Women with Diabetes Under-treated for Dyslipidemia? Sherrie H. Kaplan, PhD, MPH Professor of Medicine UCI School of Medicine Academy Health 2006 Annual.

Are Women with Diabetes Under-treated for Dyslipidemia? Sherrie H. Kaplan, PhD, MPH Professor of Medicine UCI School of Medicine Academy Health 2006 Annual.
The Scottish Health Survey: Detecting undiagnosed diabetes and pre-diabetes Catherine Bromley, ScotCen; Sarah Wild, University of Edinburgh; Helen Colhoun,

The Scottish Health Survey: Detecting undiagnosed diabetes and pre-diabetes Catherine Bromley, ScotCen; Sarah Wild, University of Edinburgh; Helen Colhoun,
Formula? Unit?.  Formula ?  Unit?  Formula?  Unit?

Formula? Unit?.  Formula ?  Unit?  Formula?  Unit?
Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.

Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.
Lowering Your Cholesterol University Medical Center Community Education Program.

Lowering Your Cholesterol University Medical Center Community Education Program.
Prevalence and management of cardiovascular risks in renal transplant recipients Dr VS Aithal Consultant Nephrologist Swansea.

Prevalence and management of cardiovascular risks in renal transplant recipients Dr VS Aithal Consultant Nephrologist Swansea.
Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial Featured Article: TODAY Study Group* Diabetes Care Volume 36: 1772-1774.

Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial Featured Article: TODAY Study Group* Diabetes Care Volume 36:
JULY 8 TH 2010 Good Morning!. Risk Factors Obesity Positive Family History Specific Ethnic Groups Gender Conditions with Insulin Resistance  Puberty.

JULY 8 TH 2010 Good Morning!. Risk Factors Obesity Positive Family History Specific Ethnic Groups Gender Conditions with Insulin Resistance  Puberty.
Electronic patient record since 2001. SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal200920102011 HbA1c > 9,0 %≤ 15%20.822.220.8.

Electronic patient record since SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal HbA1c > 9,0 %≤ 15%
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.

Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
ABERDEEN CITY DR ALASDAIR JAMIESON Clinical Lead City CHP Diabetes Full time Partner Kincorth/Cove HC.

ABERDEEN CITY DR ALASDAIR JAMIESON Clinical Lead City CHP Diabetes Full time Partner Kincorth/Cove HC.
EXAMPLE FORMULA DEFINITION 1.

EXAMPLE FORMULA DEFINITION 1.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE

Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Redefining Quality Care in T2DM Patients with CV Disease

Redefining Quality Care in T2DM Patients with CV Disease
Puberty and Ovarian Function in Girls with Type 1 Diabetes Mellitus

Puberty and Ovarian Function in Girls with Type 1 Diabetes Mellitus
Evaluation of Vascular Resistance in the Intracerebral and Extracerebral Arteries in Patients with Diabetes Mellitus type 1 - preliminary results Author:

Evaluation of Vascular Resistance in the Intracerebral and Extracerebral Arteries in Patients with Diabetes Mellitus type 1 - preliminary results Author:
M.Sc. in Pharmacy/Clinical Laboratory Sciences

M.Sc. in Pharmacy/Clinical Laboratory Sciences
Nonproliferative DR (n=24)

Nonproliferative DR (n=24)
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.

Similar presentations

Ads by Google